mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |